3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Breast Neoplasms
6
Uterine Cervical Neoplasms
2
Rectal Neoplasms
2
Prostatic Neoplasms
2
Pancreatic Neoplasms
2
Multiple Myeloma
2
Adenomatous Polyposis Coli
2
Uterine Neoplasms
1
Thrombocythemia, Essential
1
Stomach Neoplasms
1
Smoldering Multiple Myeloma
1
Sezary Syndrome
1
Radiodermatitis
1
Prostate Cancer Metastatic Castration Resistant
1
Primary Myelofibrosis
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Polycythemia Vera
1
Pain
1
Neoplasms
1
Myelodysplastic Syndromes
1
Mycosis Fungoides
1
Monoclonal Gammopathy of Undetermined Significance
1
Lymphoma, T-Cell, Cutaneous
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Head and Neck Neoplasms
1
Gastritis, Atrophic
1
Fatigue
1
Endometrial Neoplasms
1
Communicable Diseases
1
Colorectal Neoplasms
1
Interventions
Cyclophosphamide
192
Methotrexate
106
Cytarabine
86
fludarabine phosphate
80
Busulfan
71
Tacrolimus
70
Peripheral Blood Stem Cell Transplantation
69
Mycophenolic Acid
69
Whole-Body Irradiation
68
Vincristine
67
fludarabine
61
Filgrastim
61
Etoposide
59
Dexamethasone
54
Melphalan
52
Radiotherapy
47
Rituximab
46
Cyclosporine
46
Doxorubicin
38
Antilymphocyte Serum
37
Thiotepa
35
Granulocyte Colony-Stimulating Factor
35
Prednisone
34
Mercaptopurine
34
blinatumomab
33
pegaspargase
27
Methylprednisolone
27
Daunorubicin
26
Clofarabine
26
Asparaginase
25
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Precursor Cell Lymphoblastic Leukemia-Lymphoma
×
Curcumin
×
Clear all
NCT05045443
2024-01-08
CurcumPedALL
Ain Shams University
Phase 2
Completed
30 enrolled